COVID-19:アビファビル60,000人分6月病院に配布:露RDIFのアビガン後発薬(動画):  RDIF to Deliver 60,000 Courses of the First COVID-19 Drug Registered in Russia:  RDIF将提供60,000道在俄罗斯注册的首批COVID-19药物课程,

flu, Drugs, Pharmaceutical

COVID-19:インド、アビガン(Favipiravir)治験良好:Raghava Life Sciences(動画):  (RLS)Favipiravir drug working better on Covid:  (RLS)法维拉韦药物在Covid上效果更好

flu, Drugs, Pharmaceutical

COVID-19:露保健省、アビガン後発薬を暫定承認:RDIFのアビファビル(Avifavir)(動画):  Russian Ministry approves the first COVID-19 drug Avifavir by JV of RDIF/ChemRar Moscow:  俄罗斯卫生部批准了RDIF的合资企业和ChemRar Moscow共同生产的首批COVID-19药物阿维法韦,

flu, Drugs, Pharmaceutical

COVID-19:アビガン観察研究/中間報告:日本感染症学会HP(動画):  COVID-19: Avigan Observational Study Interim Report: Japanese Society of Infectious Diseases HP:  COVID-19:Avigan观察研究/中期报告:日本传染病学会

flu, Drugs, Pharmaceutical

COVID-19:宮崎大、深紫外線LED(発光ダイオード)開発:感染力99%超減少:  COVID-19: Univ of Miyazaki, deep ultraviolet LED : Infectious power decreased by over 99%:  COVID-19:宫崎大学,深紫外LED(发光二极管)开发:感染力降低了99%以上

hospital, pollution, flu, Medical care, Environment

Posts navigation